Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease

Project Information

IMMOVA

Grant agreement ID: 773570

DOI 10.3030/773570

Closed project

EC signature date 12 May 2017

Start date 1 March 2017

End date 31 August 2017

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

ALZINOVA AB
Sweden